Tamoxifen Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer
Condition:   Breast Cancer Interventions:   Drug: Fluzoparib;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Drug: Tamoxifen;   Drug: Toremifene;   Drug: Abemaciclib;   Drug: LHRH agonist Sponsor:   Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 6, 2023 Category: Research Source Type: clinical trials